PreHevbri is a vaccine for adults that is used in line with official recommendations to protect against hepatitis B (an infectious disease of the liver caused by hepatitis B virus). By preventing hepatitis B, the vaccine is also expected to protect against hepatitis D (another disease of the liver, caused by the hepatitis D virus). PreHevbri contains three proteins from the outer part of the hepatitis B virus.
Therapeutic Indication
### Therapeutic indication PreHevbri is indicated for active immunisation against infection caused by all known subtypes of the hepatitis B virus in adults. It can be expected that hepatitis D will also be prevented by immunisation with PreHevbri as hepatitis D (caused by the delta agent) does not occur in the absence of hepatitis B infection. The use of PreHevbri should be in accordance with official recommendations.
Therapeutic Area (MeSH)
N/AATC Code
J07BC01
ATC Item
hepatitis B, purified antigen
Pharmacotherapeutic Group
Vaccines
Active Substance (Summary)
INN / Common Names
N/A| Substance | CAS | Monograph |
|---|---|---|
| hepatitis B surface antigen | N/A | 乙型肝炎病毒表面抗原 |
EMA Name
PreHevbri
Medicine Name
PreHevbri
Aliases
N/ANo risk management plan link.
